Evaluation of Dienogest Treatment Efficacy in Patients with Endometriosis
article
OA: hybrid
CC0
⤵ 5 in-corpus citations
Abstract
Background The aim of the study was to evaluate the efficacy and safety of postoperative dienogest treatment in endometriosis patients. Materials and methods A total of 53 patients suffering from endometriosis were enrolled. All participants underwent laparoscopic operative treatment. Afterwards, all patients were divided into 2 groups: Group 1 (control group) and Group 2 (receiving dienogest 2 mg/day after surgery). Comparative analysis was performed evaluating patients’ condition and complaints in the postoperative period, the disease dynamics at 3 and 6 months after the surgery, pain assessment (visual analogue scale) and severity of metrorrhagia in both groups. Results Postoperative dienogest treatment reduces the severity of symptoms and improves treatment outcomes in endometriosis patients, leading to the improvement of the quality of life in these patients. Conclusions Dienogest (2 mg/day) is a highly effective drug for postoperative treatment of patients with endometriosis. Dienogest (2 mg/day) significantly decreases the severity of pelvic pain and metrorrhagia after surgery. The medication is safe and side effects are rare.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
- Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system via openalex
- Dienogest in long-term treatment of endometriosis via openalex
- Dienogest in the treatment of endometriosis via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial via openalex
- Quality of Life after Segmental Resection of the Rectosigmoid by Laparoscopy in Patients with Deep Infiltrating Endometriosis with Bowel Involvement via openalex
- Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Use of dienogest over 53 weeks for the treatment of endometriosis via openalex
- W2101417341 via openalex
- W2079421112 via openalex
- W2045458073 via openalex
Cited by (5)
- Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study 2021
- Dienogest as a Maintenance Treatment for Endometriosis Following Surgery: A Systematic Review and Meta-Analysis 2021
- Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis 2020
- The Effect of Surgical Intervention of Endometriosis to CA-125 and Pain 2020
- Progestins in the Medical Management of Endometriosis 2017
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK